Quick Answer
iSpecimen Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $9.93 million for the year ending 2023.
- iSpecimen Inc. showed a decrease of -4.6% in Revenue From Contract With Customer Excluding Assessed Tax from 2022 to 2023.
- This data is from iSpecimen Inc.'s annual report (Form 10-K), filed with the SEC on March 13, 2024.
- XBRL data for this metric is available from 2020 to 2023 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2020: $1.50 million | Q3 2020: $2.25 million | Q1 2021: $2.96 million | Q2 2021: $2.90 million | Q3 2021: $2.72 million | Q1 2022: $2.52 million | Q2 2022: $2.34 million | Q3 2022: $2.58 million | Q1 2023: $2.95 million | Q2 2023: $1.63 million | Q3 2023: $2.78 million | Q1 2024: $2.29 million | Q2 2024: $2.86 million | Q3 2024: $2.66 million.
- Over the full 4 years of available data (2020 to 2023), iSpecimen Inc.'s Revenue From Contract With Customer Excluding Assessed Tax has grown by 21.3%.
- Historical annual values: Fiscal year 2023: $9.93 million | Fiscal year 2022: $10.40 million | Fiscal year 2021: $11.14 million | Fiscal year 2020: $8.18 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: